Mcm Topical Gel Patch

L-menthol


Forreal Pharmaceuticals Llc
Human Otc Drug
NDC 81877-601
Mcm Topical Gel Patch also known as L-menthol is a human otc drug labeled by 'Forreal Pharmaceuticals Llc'. National Drug Code (NDC) number for Mcm Topical Gel Patch is 81877-601. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Mcm Topical Gel Patch drug includes Camphor (synthetic) - 96 mg/1 Levomenthol - 76.8 mg/1 Methyl Salicylate - 57.6 mg/1 . The currest status of Mcm Topical Gel Patch drug is Active.

Drug Information:

Drug NDC: 81877-601
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Mcm Topical Gel Patch
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: L-menthol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Forreal Pharmaceuticals Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Patch
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CAMPHOR (SYNTHETIC) - 96 mg/1
LEVOMENTHOL - 76.8 mg/1
METHYL SALICYLATE - 57.6 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 23 Jan, 2023
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:FORREAL PHARMACEUTICALS LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:2568113
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:5TJD82A1ET
BZ1R15MTK7
LAV5U5022Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
81877-601-153 PATCH in 1 POUCH (81877-601-15) / 5 PATCH in 1 PATCH23 Jan, 2023N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose topical analgesic

Product Elements:

Mcm topical gel patch l-menthol levomenthol levomenthol methyl salicylate salicylic acid camphor (synthetic) camphor (synthetic) butylated hydroxytoluene methylparaben polysorbate 80 castor oil sorbitol solution glycerin dihydroxyaluminum aminoacetate edetate disodium carboxymethylcellulose sodium kaolin titanium dioxide sodium polyacrylate (8000 mw) aloe vera leaf gelatin nicotinate ethanolamine tartaric acid nonivamide water

Indications and Usage:

Uses for temporary relief of minor aches and pains of muscles and joints associated with: arthritis simple backache strains bruises sprains

Warnings:

Warnings for external use only do not use on wounds or damaged skin if you are allergic to aspirin or salicylates with a heating pad with, or at the same time as other external analgesic products ask a doctor before use if you are allergic to any ingredients in this product. when using this product do not use other than directed avoid contact with eyes, mucous membranes, and rashes stop use and ask a doctor if rash, itching, or excessive skin irritation develops condition worsens symptoms persist for longer than 7 days symptoms clear up and reoccur within a few days if pregnant or breast-feeding, ask a health professional before use

Dosage and Administration:

Directions adults and children 12 years of age and over: clean and dry affected area remove patch from film apply to affected area no more than 3 to 4 times daily for 7 days remove patch from skin after at most 8 hours of application children under 12 years of age: consult a doctor

Package Label Principal Display Panel:

Principal display panel ndc: 81877-601-15 mcm topical gel patch (l-menthol 76.8 mg - methyl salicylate 57.6 mg - dl-camphor 96.0 mg) instant pain relief joint and muscle pain - sprains - backache forreal pharmaceuticals llc your solution to better healthcare (5 patches per pouch-3 pouches) 15 patches mcm topical gel patch


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.